www.dynavax.com
Open in
urlscan Pro
69.63.141.106
Public Scan
Submitted URL: http://dynavax.com/
Effective URL: https://www.dynavax.com/
Submission: On January 30 via manual from US — Scanned from DE
Effective URL: https://www.dynavax.com/
Submission: On January 30 via manual from US — Scanned from DE
Form analysis
0 forms found in the DOMText Content
Skip to main content * About * Overview * Management * Board of Directors * Scientific Advisory Board * Dynavax Europe * Product * HEPLISAV-B® * Science * Overview * Publications & Presentations * CpG 1018® * Pipeline * Clinical Trials * Investors * Overview * Press Releases * Events & Presentations * Stock Information * Analyst Coverage * Financials * SEC Filings * Annuals and Proxies * Corporate Governance and Compliance * Board of Directors * Committee Composition * Contact the Board * Contact Us * Careers * Join Our Team * Values * Job Opportunities * Benefits * Contact PREVENTING INFECTIOUS DISEASES WITH PROVEN ADJUVANT TECHNOLOGY COMMITTED TO DEVELOPING NOVEL VACCINES We are a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology. who we are MAKE A DIFFERENCE JOIN A DYNAMIC TEAM DEDICATED TO MAKING A DIFFERENCE Our mission and passion for what we do are guided by the collective ideals underpinning Our Values, and these form the basis of our company culture. Join Us EMPOWER RECENT NEWS Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights Jan 08, 2024 Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference Jan 03, 2024 Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference Nov 20, 2023 View More News DYNAVAX®, HEPLISAV-B®, and CpG 1018® are registered trademarks of Dynavax Technologies Corporation. * Home * About * Overview * Management * Board of Directors * Scientific Advisory Board * Dynavax Europe * Product * HEPLISAV-B® * Science * Overview * Publications & Presentations * CpG 1018® * Pipeline * Clinical Trials * Investors * Overview * Press Releases * Events & Presentations * Stock Information * Analyst Coverage * Financials * SEC Filings * Annuals and Proxies * Corporate Governance and Compliance * Board of Directors * Committee Composition * Contact the Board * Contact Us * Careers * Join Our Team * Values * Job Opportunities * Benefits * Contact * Twitter LinkedIn * Terms of Use * Privacy Notice © 2024 Dynavax Technologies. All rights reserved. * Terms of Use * Privacy Notice Website Design: Hane Chow, Inc. US-20-00-00098 Move to next frame Move to previous frame Close modal